Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 4, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Apr 4, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Dec 7, 2023 | CNFR | W | SU - FINAL REFUSAL - WRITTEN |
| Dec 7, 2023 | GNFR | O | FINAL REFUSAL E-MAILED |
| Dec 7, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Oct 25, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Oct 24, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 24, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 14, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| Aug 14, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Aug 14, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 17, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 17, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jul 17, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Apr 17, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| Apr 17, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Apr 17, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 8, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Mar 3, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Mar 3, 2023 | IUAF | S | USE AMENDMENT FILED |
| Aug 20, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 19, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Aug 19, 2022 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Aug 10, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 10, 2022 | EXT5 | S | SOU EXTENSION 5 FILED |
| Feb 12, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 10, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 10, 2022 | EXT4 | S | SOU EXTENSION 4 FILED |
| Feb 10, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Aug 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 10, 2021 | EXT3 | S | SOU EXTENSION 3 FILED |
| Aug 10, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Feb 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 10, 2021 | EXT2 | S | SOU EXTENSION 2 FILED |
| Feb 10, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Aug 14, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 12, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 12, 2020 | EXT1 | S | SOU EXTENSION 1 FILED |
| Aug 12, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Mar 10, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jan 14, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jan 14, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 25, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Dec 10, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 9, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Dec 9, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 9, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 20, 2019 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
Detailed Classifications
Class 044
Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals
First Use Anywhere:
20220000
First Use in Commerce:
20220000
Additional Information
Pseudo Mark
THINK INTRAVENOUS IMMUNOGLOBULIN. WRITE PRIVIGEN
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"IVIG"
USPTO Documents
Loading USPTO documents...